608 related articles for article (PubMed ID: 7665537)
1. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
2. Studies of bupropion's mechanism of antidepressant activity.
Ferris RM; Cooper BR; Maxwell RA
J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
[TBL] [Abstract][Full Text] [Related]
3. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
El Mansari M; Ghanbari R; Janssen S; Blier P
Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
Cooper BR; Wang CM; Cox RF; Norton R; Shea V; Ferris RM
Neuropsychopharmacology; 1994 Oct; 11(2):133-41. PubMed ID: 7840865
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
Cooper BR; Hester TJ; Maxwell RA
J Pharmacol Exp Ther; 1980 Oct; 215(1):127-34. PubMed ID: 6778989
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
Ferris RM; Maxwell RA; Cooper BR; Soroko FE
Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
[TBL] [Abstract][Full Text] [Related]
7. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
8. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
9. Central alpha-adrenoceptors and the mechanisms of action of antidepressant drugs.
Svensson TH
Adv Biochem Psychopharmacol; 1984; 39():241-8. PubMed ID: 6087627
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
12. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
13. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M
Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
15. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the antidepressant-like effects of sustained administration of carisbamate and lamotrigine on monoaminergic systems: electrophysiological studies in the rat brain.
Shim S; El Mansari M; Blier P
J Pharmacol Exp Ther; 2013 Nov; 347(2):487-96. PubMed ID: 23986541
[TBL] [Abstract][Full Text] [Related]
17. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
18. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.
Invernizzi RW; Garattini S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):819-27. PubMed ID: 15363606
[TBL] [Abstract][Full Text] [Related]
19. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
[TBL] [Abstract][Full Text] [Related]
20. Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
Haddjeri N; Blier P; de Montigny C
J Pharmacol Exp Ther; 1996 May; 277(2):861-71. PubMed ID: 8627568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
